IQVIA™ Real-World Insights Bibliography

Epidemiology of idiopathic thrombocytopenic purpura in Belgium assessed using hospital records.
Author(s): Gerlier L1, De Vos C1, Lamotte M1, Malfait M2, Poitrinal P3
Affiliations(s): 1 IMS Health, Brussels, Belgium 2 Amgen, Brussels, Belgium 3 Amgen, Zug, Switzerland
Publication(s):  ISPOR 11th Annual International Meeting, 2008, November 8-11, Athens, Greece
Document Type(s): Abstract,
Countries: Belgium,
C:
Y:
Hematology,
2008
  L:
A:
English
Epidemiological study,
  Add to report
 
 
A health economic evaluation of the use of erythropoiesis-stimulating agents (ESA) in patients with renal failure treated with haemodialysis.
Author(s): Van Bellinghen LA1, Lamotte M1, Malfait M2
Affiliations(s): 1 IMS Health, Brussels, Belgium 2 Amgen, Brussels, Belgium
Publication(s):  ISPOR 11th Annual International Meeting, 2008, November 8-11, Athens, Greece
Document Type(s): Abstract,
Countries: Belgium,
C:
Y:
Hematology,
2008
  L:
A:
English
Economic evaluation,
  Add to report
 
 
Cost-effectiveness of enoxaparin as prophylactic therapy versus unfractionated heparin or no prophylaxis in hospitalised medical patients
Author(s): Feng J, Yuen C, Jackson D
Affiliations(s): 
Publication(s):  ISPOR 11th Annual European Congress 8?11 November 2008 Athens Greece
ISPOR 11th Annual European Congress, Athens Greece. November 2008
Document Type(s): Oral presentation, Poster,
Countries: 
C:
Y:
Hematology, Vascular disease,
2008
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Myelodysplastic Syndromes: Aspects of current medical care and economic considerations in Germany
Author(s): Gattermann N 1, Hofmann WK 2, Meeßen A 3, Schmitz S 4, Tsamaloukas A 5, Vollmer T 6, Wedding U 7, Plesnila-Frank C 8, Schramm W 9, Berger K 8
Affiliations(s): 1 Universitätsklinukum Düsseldorf,Germany 2 Charité Campus Benjamin Franklin, Berlin, Germany 3 Verband der Angestellten-Krankenkassen e.V. / Arbeiter-Ersatzkassen-Verband e.V., Siegburg, Germany 4 Hämatologe/Onkologe, Cologne, Germany 5 Internist/Onkologe, Hilden, Germany 6 Psycho-Onkologin, Rotterdam, Netherlands 7 Universitätsklinikum Jena, Germany 8 IMS Health, Munich, Germany 9 Klinikum der Universität München, Munich, Germany
Publication(s):  Onkologie 2008; 31: 477-84.
Document Type(s): Article,
Countries: Germany,
Click here for the abstract
C:
Y:
Hematology,
2008
  L:
A:
English
Workshop,
  Add to report
 
 
The importance of anaemia in diagnosing colorectal cancer: a case-control study using electronic primary care records.
Author(s): Hamilton W, Lancashire R, Sharp D, Peters T J, Cheng K & Marshall T
Affiliations(s): Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol
Publication(s):  Br J Cancer. 2008 Jan 29;98(2):323-7. doi: 10.1038/sj.bjc.6604165. Epub 2008 Jan 22.
Document Type(s): Abstract,
Countries: UK,
Click here for the abstract
C:
Y:
Hematology, Oncology,
2008
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after total hip replacement in Spain.
Author(s): Diamantopoulos A1, Forster F1, Brosa M2, Lees M3, Piñol C4, Febrer L4
Affiliations(s): 1IMS Health, London, UK, 2Oblikue Consulting, Barcelona, Spain, 3Bayer HealthCare, Uxbridge, UK, 4Bayer HealthCare, Barcelona, Spain
Publication(s):  ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11,
Document Type(s): Poster,
Countries: Spain,
C:
Y:
Hematology,
2007
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Cost-Effectiveness of Rivaroxaban versus Enoxaparin for Thromboprophylaxis after total hip replacement in the UK.
Author(s): Diamantopoulos A1, Forster F1, Lees M2, Gilmour L3, Ashley D4
Affiliations(s): 1IMS Health, London, UK, 2Bayer HealthCare, Uxbridge, UK, 3Bayer Healthcare Pharmaceuticals Inc, Newbury, Berkshire, UK, 4Bayer Healthcare Pharmaceuticals Inc, Newbury, UK
Publication(s):  ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11,2008
Document Type(s): Poster,
Countries: UK,
C:
Y:
Hematology,
2007
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Prophylaxis with Rivaroxaban against Venous Thromboembolism (VTE): A Cost-Consequence Analysis from the perspective of the Italian Healthcare Service.
Author(s): Negrini C1, Diamantopoulos A2, Forster F2, Lopatriello S3, Lees M4, Bianchi C5, Pedone MP5
Affiliations(s): 1PBE Consulting, Milano, Italy, 2IMS Health, London, UK, 3Pbe Consulting, Verona, Italy, 4Bayer HealthCare, Uxbridge, UK, 5Bayer HealthCare, Milan, Italy
Publication(s):  ISPOR 11th Annual European Congress, 2008, Athens, Greece; November 8-11, 2008
Document Type(s): Poster,
Countries: Italy,
C:
Y:
Hematology,
2007
  L:
A:
English
Cost consequence,
  Add to report
 
 
Assesment of the economic value of the INTERCEPT blood system in Belgium.
Author(s): Moeremans K, Warie H, Annemans L
Affiliations(s): 
Publication(s):  Transfus Med.; 16:17-30
Document Type(s): Manuscript in preparation,
Countries: Belgium,
C:
Y:
Hematology,
2006
  L:
A:
English
  Add to report
 
 
Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting
Author(s): Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R & Vallance P
Affiliations(s): Department of Epidemiology, London School of Hygiene and Tropical Medicine
Publication(s):  Lancet. 2006 Apr 1;367(9516):1075-9.
Document Type(s): Abstract, Article,
Countries: UK,
Click here for the abstract
C:
Y:
Hematology, Respiratory disease,
2006
  L:
A:
English
Retrospective database analysis,
  Add to report
 
 
First Page Previous Page  8 of 8